Adverse drug reactions in paediatric patients. A pharmacovigilance investigation in Sicily;Reazioni avverse da farmaci in eta pediatrica. Studio di farmacovigilanza in Sicilia

Recenti Progressi in Medicina

Volumn 89, Issue 6, 1998, Pages 290-295

  Cutroneo, Paola M ^a   Arcoraci, Vincenzo ^a   Cucinotta, Giovanni ^a   Inferrera, Giuseppina ^a   Galante, Franca ^b   Sofia, Agata ^c   Ferrera, Eleonora ^d   Napolitano, Teresa ^e   Mazzaglia, Giampiero ^a   Caputi, Achille P ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b ASL 6   (Italy)

^c Servizio Medicina di Base   (Italy)

^d Servizio di Medicina di Base   (Italy)

^e MAGGIORE HOSPITAL   (Italy)

Author keywords

Adverse drug reactions; Paediatric patients; Pharmacovigilance; Spontaneous reports

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; AZITHROMYCIN; CEFACLOR; CEFTRIAXONE; COTRIMOXAZOLE; CYTARABINE; FELBAMATE; FEPRAZONE; FLURBIPROFEN; GASTROINTESTINAL AGENT; HEPATITIS B VACCINE; IMMUNOMODULATING AGENT; KETOPROFEN; MEROPENEM; METHYLPHENOBARBITAL; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PHENYTOIN;

ARTICLE; DRUG SURVEILLANCE PROGRAM; HOSPITAL; HUMAN; ITALY; PEDIATRICS; PHYSICIAN; PRIMARY MEDICAL CARE; SIDE EFFECT; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGE FACTORS; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; INFANT, NEWBORN; ITALY; PHARMACEUTICAL PREPARATIONS;

EID: 7144259742     PISSN: 00341193     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Naldi L, Franzosi MG, Liati P, La Vecchia C, Tognoni G. Il problema della sorveglianza sui farmaci. Informazioni sui Farmaci 1985; 4: 303-10.
2. Caputi AP, Mazzaglia G, Inferrera G. Le reazioni avverse ai farmaci: segnalazioni e sistemi di sorveglianza del Ministero della Sanità. Professione, Sanità Pubblica e Medicina Preventiva 1996; 4: 6-11.
3. Wiholm BE, Olsson S, Moore N, Wood S. Spontaneous reporting systems outside the United States. In: Brian L. Strom, eds. Pharmacoepidemiology, 2nd ed. Philadelphia: Wiley 1994; 139-155.
4. Rawlins MD. Spontaneous reporting of adverse drug reactions. 1: The data. Br J Clin Pharmacol 1988; (26): 1-5.
5. Caputi AP, Greco S. La farmacovigilanza in Sicilia. La Rivista del Medico Pratico 1997; 526 (suppl. 2: Boll. Farmacovigilanza): 1-4.
6. Bonati M. Epidemiologic evaluation of drug use in children. J Clin Pharmacol 1994; 34: 300-05.
7. Soumerai SB, Ross-Degnan D. Drug prescribing in pediatrics: challenge for quality improvement. Pediatrics 1990; 86: 782-84.
8. Spielberg SP. Paediatrics therapeutics and drug utilization. Pharmacoepydemiology and Drug Safety 1992; 1: 31-2.
9. Choonara J, Gill A, Nunn A. Drug toxicity and surveillance in children. Br J Clin Pharmacol 1996; 42: 407-10.
10. Impicciatore P, Addis A, Miglio D, Pistotti V, Bonati M. Reazioni avverse da farmaci in pediatria di base. Ricerca & Pratica 1995; 11: 96-106.
11. Mitchell AA, Lacouture PG, Sheenan JE, Kauffman RE, Shapiro S. Adverse drug reactions in children leading to hospital admission. Pediatrics 1988; 82: 24-9.
12. Martinez-Mir I, Garcia-Lopez M, Palop V, Ferrer JM, Estan L, Rubio E, Morales-Olivas FJ. A prospective study of adverse drug reactions as a cause of admission to a paediatric hospital. Br J Clin Pharmacol 1996; 319-24.
13. Anonymous: ADROIT moves on drugs. Lancet 1991; 338: 1326.
14. Sanz E, Boada J. Adverse drug reactions in paediatric outpatients. Int J Clin Pharmacol Res 1987; 7: 169-72.
15. Wesslin A, Soderman P, Boethius G. Monitoring of drug prescriptions for children in the County of Jamtland and in Sweden as a whole in 1977-97. Acta Paediatr Scand 1991; 80: 944-52.
16. Ministero della Sanità. Sistema Informativo Sanitario: Rapporte delle segnalazioni di effetti collaterali da farmaci. Anni 1992-1993-1994. A cura della Direzione Generale del Servizio Farmaceutico.
17. Kramer MS, Hutchinson TA, Flegel KM, Naimark L, Contardi R, Leduc DG. Adverse drug reactions in general paediatric outpatients. J Pediatr 1985; 106: 305-10.